A childhood epilepsy mutation reveals a role for developmentally regulated splicing of a sodium channel

Ruwei Xu1, Evan A Thomas, Misty Jenkins

  • 1Howard Florey Institute, The University of Melbourne, Parkville, Victoria, 3010, Melbourne, Australia.

Insights

Neonatal seizures are linked to specific sodium channel (NaV1.2) mutations that increase neural excitability. This study reveals how these mutations affect neonatal channels, offering insights into benign familial neonatal-infantile seizures (BFNIS).

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Genetics

Background:

  • Infants exhibit higher seizure susceptibility than adults, attributed to developmental neural excitability changes.
  • Benign familial neonatal-infantile seizures (BFNIS) are linked to mutations in the human sodium channel gene (NaV1.2).

Purpose of the Study:

  • To investigate the functional impact of a BFNIS-associated mutation (L1563V) on neonatal and adult splice forms of the NaV1.2 sodium channel.
  • To elucidate the molecular mechanisms underlying BFNIS and normal infant seizure regulation.

Main Methods:

  • Analysis of neonatal and adult NaV1.2 splice variants with the L1563V mutation in human embryonic kidney cells.
  • Utilizing computer modeling to assess channel excitability.

Main Results:

  • Neonatal NaV1.2 channels were found to be less excitable than adult channels.
  • The L1563V mutation increased neonatal channel excitability to adult levels, while adult channels were unaffected.
  • This mutation-induced "adult-like" excitability in neonatal channels is implicated in BFNIS.

Conclusions:

  • Developmentally regulated NaV1.2 splicing plays a role in reducing seizure susceptibility in normal infants.
  • The study provides a molecular explanation for BFNIS, highlighting the critical role of NaV1.2 channel function in early life neurodevelopment.

Related Concept Videos

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...